Skip to main content

Advertisement

Log in

Facial Pain Update: Advances in Neurostimulation for the Treatment of Facial Pain

  • Other Pain (N Vadivelu and A Kaye, Section Editors)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Craniofacial pain, including trigeminal neuralgia, trigeminal neuropathic pain, and persistent idiopathic facial pain, is difficult to treat and can have severe implications for suffering in patients afflicted with these conditions. In recent years, clinicians have moved beyond treating solely with pharmacological therapies, which are generally not very effective, and focused on new interventional pain procedures. These procedures have evolved as technology has advanced, and thus far, early results have demonstrated efficacy in small patient cohorts with a variety of craniofacial pain states. Some of the most promising interventional pain procedures include peripheral nerve field stimulation, high-frequency spinal cord stimulation, sphenopalatine ganglion stimulation, and deep brain stimulation. This review focuses on a better understanding of craniofacial pain and emerging interventional pain therapies. With the advent of newer miniature wireless devices and less invasive implantation techniques, this should allow for more widespread use of neurostimulation as a therapeutic modality for treating craniofacial pain. Larger studies should assist in best practice strategies vis-à-vis traditional pharmacological therapies and emerging interventional pain techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Sharma M, Shaw A, Deogaonkar M. Surgical options for complex craniofacial pain. Neurosurg Clin N Am. 2014;25(4):763–75.

    Article  PubMed  Google Scholar 

  2. Stookey B, Ransohoff J. Trigeminal neuralgia. Its history and treatment. Springfield, IL: Charles C. Thomas; 1959.

    Google Scholar 

  3. Eboli P, Stone JL, Audin S, Slavin KV. Historical characterization of trigeminal neuralgia. Neurosurgery. 2009;64:1183–7.

    Article  PubMed  Google Scholar 

  4. Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review). Neurology. 2008;71:1183–90.

    Article  CAS  PubMed  Google Scholar 

  5. Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain. 2002;18(6):343–9.

    Article  PubMed  Google Scholar 

  6. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60:1524–34.

    Article  PubMed  Google Scholar 

  7. Hodaie M, Coello AF. Advances in the management of trigeminal neuralgia. J Neurosurg Sci. 2013;57:13–21.

    CAS  PubMed  Google Scholar 

  8. Feletti A, Santi GZ, Sammartino F, et al. Peripheral trigeminal nerve field stimulation: report of 6 cases. Neurosurg Focus. 2013;35(3):E10.

    Article  PubMed  Google Scholar 

  9. Mueller D, Obermann M, Yoon MS, et al. Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia. 2011;31(15):1542–8.

    Article  PubMed  Google Scholar 

  10. Headache Classification Committee. The international classification of headache disorders, 3rd edition (beta version). 5. Cephalalgia. 2013;33:629–808.

    Article  Google Scholar 

  11. Obermann M, Holle D, Katsarava Z. Trigeminal neuralgia and persistent idiopathic facial pain. Expert Rev Neurother. 2011;11(11):1619–29.

    Article  PubMed  Google Scholar 

  12. Goadsby P, Hoskin K. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study. J Anat. 1997;190:367–75.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Goadsby PJ, Bartsch T, Dodick D. Occipital nerve stimulation for headache: mechanisms and efficacy. Headache. 2008;48:313–8.

    Article  PubMed  Google Scholar 

  14. Hassanzadeh R, Jones JC, Ross EL. Neuromodulation for intractable headaches. Curr Pain Headache Rep. 2014;18(392):1–8.

    Google Scholar 

  15. Jannetta PJ, McLaughlin MR, Casey KF. Technique of microvascular decompression. Neurosurg Focus. 2005;18:1–5.

    Google Scholar 

  16. Koopman J, De Vries LM, Dieleman JP, Huygen FJ, Stricker BHC, Sturkenboom MCJM. A nationwide study of three invasive treatments for trigeminal neuralgia. Pain. 2011;152:507–13.

    Article  PubMed  Google Scholar 

  17. Zakrzewska JM. Diagnosis and differential diagnosis of trigeminal neuralgia. Clin J Pain. 2002;18:14–21.

    Article  PubMed  Google Scholar 

  18. Cole CD, Liu JK, Apfelbaum RI. Historical perspectives on the diagnosis and treatment of trigeminal neuralgia. Neurosurg Focus. 2005;18:1–10.

    Article  Google Scholar 

  19. Ma Z, Li M. Nerve combing for trigeminal neuralgia without vascular compression. Clin J Pain. 2009;25:44–7.

    Article  CAS  PubMed  Google Scholar 

  20. Sekula Jr RF et al. Microvascular decompression for elderly patients with trigeminal neuralgia; a prospective study and systematic review with meta-analysis. J Neurosurg. 2011;114(1):172–9.

    Article  PubMed  Google Scholar 

  21. Zakrzewska J, Coakham HB. Microvascular decompression for trigeminal neuralgia. Curr Opin Neurol. 2012;25:296–301.

    Article  PubMed  Google Scholar 

  22. Zakrzewska J, Lopez BC. New techniques for surgical management of trigeminal neuralgia. Letter to the editor. Pain. 2004;109:520–9.

    Article  PubMed  Google Scholar 

  23. Wall PD, Sweet WH. Temporary abolition of pain in man. Science. 1967;155(3758):108–9.

    Article  CAS  PubMed  Google Scholar 

  24. Ellis JA, Munne Mejia JC, Winfree CJ. Trigeminal branch stimulation for the treatment of intractable craniofacial pain. J Neurosurg. 2015;123:283–8.

    Article  PubMed  Google Scholar 

  25. Klein J, Sandi-Gahun S, Schackert G, Juratli TA. Peripheral nerve field stimulation for trigeminal neuralgia, trigeminal neuropathic pain, and persistent idiopathic facial pain. Cephalalgia. 2015;1–9. This case report shows the success of peripheral nerve field stimulation as a treatment for intractable facial pain, trigeminal neuralgia, and trigeminal neuropathic pain when first-line therapies have failed.

  26. Deer TR, Mekhail N, et al. The appropriate use of neurostimulation: stimulation of the intracranial and extracranial space and head for chronic pain. Neuromodulation: Technol Neural Interface. 2014;17.6:551–70. Based on the most current literature, research, and clinical experience, this review paper written by the Neuromodulation Appropriateness Consensus Committee concluded that extracranial nerve stimulation should be considered in the algorithmic treatment of migraine and other disorders of the head.

    Article  Google Scholar 

  27. Yearwood L, Thomas PL. Peripheral neurostimulation with a microsize wireless stimulator. Prog Neurol Surg. 2015;29:168–91.

    Article  PubMed  Google Scholar 

  28. Bioness® StimRouterTM Neuromodulation System for Chronic Pain Therapy. http://clinicaltrials.gov/ct2/show/NCT01592344?term=stimrouter&rank=2.

  29. Hudson J. Stimwave receives FDA clearance and launches commercialization for world’s smallest fully-programmable, eight-electrode wireless pain relief SCS system. Stimwave receives FDA clearance and launches commercialization for world’s smallest fully-programmable, eight-electrode wireless pain Relief SCS system. BUSINESS WIRE, 9 Dec. 2015. Web. This is the first FDA-approved commercially available wireless spinal cord stimulator implant. While not yet approved for facial pain, due to its small size and ease of implantation, this device would be ideal for the treatment of facial neuralgias.

  30. Salar G, Ori C, Iob I, Fiore D. Percutaneous thermocoagulation for sphenopalatine ganglion neuralgia. Acta Neurochir. 1987;84:24–8.

    Article  CAS  PubMed  Google Scholar 

  31. Elahi F. Sphenopalatine ganglion electrical nerve stimulation implant for intractable facial pain. Pain Physician. 2015;18.3:403–9. This is the first reported case of sphenopalatine ganglion stimulation successfully used to treat intractable facial pain. This may offer another treatment option for those patients who have failed more conservative therapies.

    Google Scholar 

  32. Kapural L, Yu C, et al. Novel 10-kHz high-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain. Anesthesiology. 2015;123(4):851–60.

    Article  PubMed  Google Scholar 

  33. North RB, Kidd D, Shipley J, et al. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized, controlled trial. Neurosurgery. 2007;61(2):361–8.

    Article  PubMed  Google Scholar 

  34. Barolat G, Knobler RL, Lublin FD. Trigeminal neuralgia in a patient with multiple sclerosis treated with high cervical spinal cord stimulation. Case report. Appl Neurophysiol. 1988;51(6):333–7.

    CAS  PubMed  Google Scholar 

  35. Simpson BA, Bassett G, Davies K, et al. Cervical spinal cord stimulation for pain: a report on 41 patients. Neuromodulation. 2003;6(1):20–6.

    Article  PubMed  Google Scholar 

  36. Tomycz ND, Deibert CP, Moossy JJ. Cervicomedullary junction spinal cord stimulation for head and facial pain. Headache. 2011;51(3):418–25.

    Article  PubMed  Google Scholar 

  37. Boccard SGJ, Pereira EAC. Deep brain stimulation for chronic pain. J Clin Neurosci. 2015;22(10):1537–43.

    Article  PubMed  Google Scholar 

  38. Kumar K, Toth C, Nath RK. Deep brain stimulation for intractable pain: a 15-year experience. Neurosurgery. 1997;40:736–46.

    Article  CAS  PubMed  Google Scholar 

  39. Nandi D, Smith H, Owen S, et al. Periventricular grey stimulation versus motor cortex stimulation for post stroke neuropathic pain. J Clin Neurosci. 2002;9:557–61.

    Article  PubMed  Google Scholar 

  40. Hosobuchi Y, Adams JE, Linchitz R. Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone. Science. 1977;197:183–6.

    Article  CAS  PubMed  Google Scholar 

  41. Romanelli P, Esposito V. The functional anatomy of neuropathic pain. Neurosurg Clin N Am. 2004;15:257–68.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard D. Urman.

Ethics declarations

Conflict of Interest

Rajivan Maniam, Alan David Kaye, and Nalini Vadivelu declare that they have no conflict of interest.

Richard D. Urman declares grants from Mallinckrodt, Inc. and Cara/Premier Pharma, Inc., and personal fees from Merck, Inc.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Other Pain

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maniam, R., Kaye, A.D., Vadivelu, N. et al. Facial Pain Update: Advances in Neurostimulation for the Treatment of Facial Pain. Curr Pain Headache Rep 20, 24 (2016). https://doi.org/10.1007/s11916-016-0553-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-016-0553-0

Keywords

Navigation